I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Hirakawa, Masahiro
251
results:
Search for persons
X
Format
Online (251)
Mediatypes
Articles (Online) (174)
OpenAccess-fulltext (77)
Sorted by: Relevance
Sorted by: Year
?
1
Sa1530 PERCENTAGE OF BACTEROIDES SPEICIES IN MICROBIOME AFF..:
Nagashima, Hiroyuki
;
Sagawa, Tamotsu
;
Hirakawa, Masahiro
Gastroenterology. 166 (2024) 5 - p. S-1571 , 2024
Link:
https://doi.org/10.1016/..
?
2
Hilar/mediastinal and cutaneous drug-induced sarcoidosis-li..:
Sagawa, Tamotsu
;
Sato, Yasushi
;
Nagashima, Hiroyuki
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
3
Case Report: Longitudinal monitoring of clonal evolution by..:
Sagawa, Tamotsu
;
Sato, Yasushi
;
Hirakawa, Masahiro
...
Frontiers in Oncology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
4
Maturation and Phenotypic Heterogeneity of Human CD4+ Regul..:
Matos, Tiago R.
;
Hirakawa, Masahiro
;
Alho, Ana C.
...
Frontiers in Immunology. 11 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
5
Sa1484 COMBINED NIVOLUMAB PLUS IPILIMUMAB THERAPY CAUSE HIG..:
Nagashima, Hiroyuki
;
Sagawa, Tamotsu
;
Hirakawa, Masahiro
...
Gastroenterology. 158 (2020) 6 - p. S-1307 , 2020
Link:
https://doi.org/10.1016/..
?
6
Hyperemesis-induced Wernicke-Korsakoff Syndrome due to Hype..:
Miyanaga, Rei
;
Hisahara, Shin
;
Ohhashi, Ikkei
...
Internal Medicine. 59 (2020) 21 - p. 2783-2787 , 2020
Link:
https://doi.org/10.2169/..
?
7
Clinical impact of primary tumour location, early tumour sh..:
Sagawa, Tamotsu
;
Sato, Yasushi
;
Hirakawa, Masahiro
...
Scientific Reports. 10 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1038/..
?
8
Management of Multiple Arteriovenous Malformations of the S..:
Hirakawa, Masahiro
;
Ishizuka, Rie
;
Sato, Masanori
...
Case Reports in Medicine. 2019 (2019) - p. 1-4 , 2019
Link:
https://doi.org/10.1155/..
?
9
Total buried bumper syndrome: A case study in transabdomina..:
Nakamura, Hajime
;
Kikuchi, Shohei
;
Ohnuma, Hiroyuki
..
Clinical Case Reports. 7 (2019) 10 - p. 2012-2013 , 2019
Link:
https://doi.org/10.1002/..
?
10
Low-Dose Interleukin-2 Therapy Activates Circulating T Foll..:
Kamihara, Yusuke
;
Forcade, Edouard
;
Koreth, John
...
Biology of Blood and Marrow Transplantation. 24 (2018) 3 - p. S72 , 2018
Link:
https://doi.org/10.1016/..
?
11
Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fl..:
Ohnuma, Hiroyuki
;
Sato, Yasushi
;
Hayasaka, Naotaka
...
Cancer Science. 109 (2018) 11 - p. 3554-3563 , 2018
Link:
https://doi.org/10.1111/..
?
12
Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy..:
Ohnuma, Hiroyuki
;
Sato, Yasushi
;
Hirakawa, Masahiro
...
Cancer Chemotherapy and Pharmacology. 81 (2018) 3 - p. 539-548 , 2018
Link:
https://doi.org/10.1007/..
?
13
A dose-escalation study of docetaxel, oxaliplatin, and S-1 ..:
Sato, Yasushi
;
Sagawa, Tamotsu
;
Ohnuma, Hiroyuki
...
Cancer Chemotherapy and Pharmacology. 83 (2018) 1 - p. 161-167 , 2018
Link:
https://doi.org/10.1007/..
?
14
A phase II study of modified docetaxel, cisplatin, and S-1 ..:
Uemura, Naoki
;
Kikuchi, Shohei
;
Sato, Yasushi
...
Cancer Chemotherapy and Pharmacology. 80 (2017) 4 - p. 707-713 , 2017
Link:
https://doi.org/10.1007/..
?
15
A triplet combination with capecitabine/oxaliplatin/irinote..:
Sato, Yasushi
;
Hirakawa, Masahiro
;
Ohnuma, Hiroyuki
...
Cancer Chemotherapy and Pharmacology. 80 (2017) 6 - p. 1133-1139 , 2017
Link:
https://doi.org/10.1007/..
1-15